Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 101

1.

Effects of the Dietary ω3:ω6 Fatty Acid Ratio on Body Fat and Inflammation in Zebrafish (Danio rerio).

Powell ML, Pegues MA, Szalai AJ, Ghanta VK, D'Abramo LR, Watts SA.

Comp Med. 2015 Aug;65(4):289-94.

2.

XIAP-mediated protection of H460 lung cancer cells against cisplatin.

Cheng YJ, Jiang HS, Hsu SL, Lin LC, Wu CL, Ghanta VK, Hsueh CM.

Eur J Pharmacol. 2010 Feb 10;627(1-3):75-84. doi: 10.1016/j.ejphar.2009.11.003. Epub 2009 Nov 10.

PMID:
19903469
3.

Molecules involve in the self-protection of neurons against glucose-oxygen-serum deprivation (GOSD)-induced cell damage.

Wang CH, Lee WJ, Ghanta VK, Wang WT, Cheng SY, Hsueh CM.

Brain Res Bull. 2009 May 29;79(3-4):169-76. doi: 10.1016/j.brainresbull.2009.02.006. Epub 2009 Mar 3.

PMID:
19429187
4.

Ischemic brain cell-derived conditioned medium protects astrocytes against ischemia through GDNF/ERK/NF-kB signaling pathway.

Chu LF, Wang WT, Ghanta VK, Lin CH, Chiang YY, Hsueh CM.

Brain Res. 2008 Nov 6;1239:24-35. doi: 10.1016/j.brainres.2008.08.087. Epub 2008 Sep 10.

PMID:
18804095
5.

Cytokine and hormone profiles in mice subjected to handling combined with rectal temperature measurement stress and handling only stress.

Hale KD, Weigent DA, Gauthier DK, Hiramoto RN, Ghanta VK.

Life Sci. 2003 Feb 14;72(13):1495-508.

PMID:
12535717
6.

Effects of rotational stress of different duration on NK cell activity, proinflammatory cytokines, and POMC-derived peptides in mice.

Hale KD, Ghanta VK, Gauthier DK, Hiramoto RN.

Neuroimmunomodulation. 2001;9(1):34-40.

PMID:
11435750
7.

NK cell and CTL activities can be raised via conditioning of the CNS with unrelated unconditioned stimuli.

Demissie S, Ghanta VK, Hiramoto NS, Hiramoto RN.

Int J Neurosci. 2000 Jul-Aug;103(1-4):79-89.

PMID:
10938565
8.

Psychoneuroendocrine immunology: perception of stress can alter body temperature and natural killer cell activity.

Hiramoto RN, Solvason HB, Hsueh CM, Rogers CF, Demissie S, Hiramoto NS, Gauthier DK, Lorden JF, Ghanta VK.

Int J Neurosci. 1999;98(1-2):95-129. Review.

PMID:
10395364
9.

Afferent signals to the CNS appear not to condition the modulation of interleukin-1 receptors in the hippocampus.

Demissie S, Ban EE, Rogers CF, Hiramoto NS, Ghanta VK, Hiramoto RN.

Neuroimmunomodulation. 1997 Sep-Dec;4(5-6):298-304.

PMID:
9650824
10.

Psychoneuroendocrine immunology: site of recognition, learning and memory in the immune system and the brain.

Hiramoto RN, Rogers CF, Demissie S, Hsueh CM, Hiramoto NS, Lorden JF, Ghanta VK.

Int J Neurosci. 1997 Dec;92(3-4):259-85. Review.

PMID:
9522270
11.

Involvement of cytokine gene expression in the age-dependent decline of NK cell response.

Hsueh CM, Chen SF, Ghanta VK, Hiramoto RN.

Cell Immunol. 1996 Nov 1;173(2):221-9.

PMID:
8912880
12.

Activation of mu-opioid receptors are required for the conditioned enhancement of NK cell activity.

Hsueh CM, Chen SF, Huang HJ, Ghanta VK, Hiramoto RN.

Brain Res. 1996 Oct 21;737(1-2):263-8.

PMID:
8930374
13.

Conditioning of body temperature and natural killer cell activity with arecoline, a muscarinic cholinergic agonist.

Ghanta VK, Demissie S, Hiramoto NS, Hiramoto RN.

Neuroimmunomodulation. 1996 Jul-Aug;3(4):233-8.

PMID:
9094445
14.

Lipopolysaccharide and IL-1 alpha activate CNS pathways as measured by NK cell activity.

Demissie S, Rogers CF, Hiramoto NS, Ghanta VK, Hiramoto RN.

Physiol Behav. 1996 Mar;59(3):499-504.

PMID:
8700953
15.

Arecoline a muscarinic cholinergic agent conditions central pathways that modulate natural killer cell activity.

Demissie S, Rogers CF, Hiramoto NS, Ghanta VK, Hiramoto RN.

J Neuroimmunol. 1995 Jun;59(1-2):57-63.

PMID:
7797620
16.

Expression of the conditioned NK cell activity is beta-endorphin dependent.

Hsueh CM, Chen SF, Ghanta VK, Hiramoto RN.

Brain Res. 1995 Apr 24;678(1-2):76-82.

PMID:
7620901
17.

Conditioning of the secondary cytotoxic T-lymphocyte response to YC8 tumor.

Ghanta VK, Hiramoto NS, Soong SJ, Hiramoto RN.

Pharmacol Biochem Behav. 1995 Mar;50(3):399-403.

PMID:
7617678
18.

Effect of dexamethasone on conditioned enhancement of natural killer cell activity.

Hsueh CM, Rogers C, Hiramoto RN, Ghanta VK.

Neuroimmunomodulation. 1994 Nov-Dec;1(6):370-6.

19.

Lidocaine interrupts the conditioned natural killer cell response by interfering with the conditioned stimulus.

Rogers CF, Ghanta VK, Demissie S, Hiramoto N, Hiramoto RN.

Neuroimmunomodulation. 1994 Sep-Oct;1(5):278-83.

PMID:
8528893
20.

Use of an allogeneic antigen to induce resistance and regression of an autologous tumor.

Hiramoto RN, Ghanta VK, Soong SJ, Hiramoto NS.

J Immunother Emphasis Tumor Immunol. 1994 Apr;15(3):202-11.

PMID:
8032543
21.

Role of arcuate nucleus of the hypothalamus in the acquisition of association memory between the CS and US.

Ghanta VK, Rogers CF, Hsueh CM, Demissie S, Lorden JF, Hiramoto NS, Hiramoto RN.

J Neuroimmunol. 1994 Feb;50(1):109-14.

PMID:
8300852
22.

Efferent signal(s) responsible for the conditioned augmentation of natural killer cell activity.

Hsueh CM, Tyring SK, Hiramoto RN, Ghanta VK.

Neuroimmunomodulation. 1994 Jan;1(1):74-81.

PMID:
8528888
23.

A multiple modality approach combining the effect of conditioning with adoptive chemoimmunotherapy.

Ghanta VK, Hiramoto NS, Soong SJ, Miller DM, Hiramoto RN.

Int J Neurosci. 1993 Jul-Aug;71(1-4):251-65.

PMID:
8407150
24.

The identity of the unconditioned stimulus to the central nervous system is interferon-beta.

Solvason HB, Ghanta VK, Hiramoto RN.

J Neuroimmunol. 1993 Jun;45(1-2):75-81.

PMID:
8331167
25.

Conditioning of the allogeneic cytotoxic lymphocyte response.

Hiramoto RN, Hsueh CM, Rogers CF, Demissie S, Hiramoto NS, Soong SJ, Ghanta VK.

Pharmacol Biochem Behav. 1993 Feb;44(2):275-80.

PMID:
8446660
26.

The central effect of methionine-enkephalin on NK cell activity.

Hsueh CM, Hiramoto RN, Ghanta VK.

Brain Res. 1992 Apr 24;578(1-2):142-8.

PMID:
1511272
27.

A simple, single, trial-learning paradigm for conditioned increase in natural killer cell activity.

Solvason HB, Ghanta VK, Soong SJ, Rogers CF, Hsueh CM, Hiramoto NS, Hiramoto RN.

Proc Soc Exp Biol Med. 1992 Feb;199(2):199-203.

PMID:
1741412
28.

Acquisition of enhanced natural killer cell activity under anesthesia.

Hsueh CM, Lorden JF, Hiramoto RN, Ghanta VK.

Life Sci. 1992;50(26):2067-74.

PMID:
1608290
29.

A behavioral augmentation of natural immunity: odor specificity supports a Pavlovian conditioning model.

Solvason HB, Ghanta VK, Lorden JF, Soong SJ, Hiramoto RN.

Int J Neurosci. 1991 Dec;61(3-4):277-88.

PMID:
1824390
30.

In vivo enhancement of NK cell activity with met-enkephalin and glycyl-glutamine: their possible role in the conditioned response.

Ghanta VK, Rogers CF, Hsueh CM, Hiramoto NS, Soong SJ, Hiramoto RN.

Int J Neurosci. 1991 Nov;61(1-2):135-43.

PMID:
1809731
31.

Role of immune cells in the Pavlovian conditioning of specific resistance to cancer.

Hiramoto RN, Hiramoto NS, Rish ME, Soong SJ, Miller DM, Ghanta VK.

Int J Neurosci. 1991 Jul;59(1-3):101-17.

PMID:
1774131
32.

Effect of thymic hormone treatment on several immune functions of nude mice.

Ghanta VK, Hiramoto NS, Soong SJ, Hiramoto RN.

Mech Ageing Dev. 1991 May;58(2-3):245-54.

PMID:
1875732
33.

Conditioning the elevation of body temperature, a host defensive reflex response.

Hiramoto RN, Ghanta VK, Rogers CF, Hiramoto NS.

Life Sci. 1991;49(2):93-9.

PMID:
2062174
34.

Survey of thymic hormone effects on physical and immunological parameters in C57BL/6NNia mice of different ages.

Ghanta VK, Hiramoto NS, Soong SJ, Hiramoto RN.

Ann N Y Acad Sci. 1991;621:239-55.

PMID:
1859089
35.

Conditioning: a new approach to immunotherapy.

Ghanta VK, Hiramoto NS, Solvason HB, Soong SJ, Hiramoto RN.

Cancer Res. 1990 Jul 15;50(14):4295-9.

36.

Thymic peptides as anti-aging drugs: effect of thymic hormones on immunity and life span.

Ghanta VK, Hiramoto NS, Hiramoto RN.

Int J Neurosci. 1990 Apr;51(3-4):371-2. No abstract available.

PMID:
2279904
37.
38.

Characterization of 5B12.1, a monoclonal antibody specific for IL-6.

Sawamura M, Everson MP, Shrestha K, Ghanta VK, Miller DM, Hiramoto RN.

Growth Factors. 1990;3(3):181-90.

PMID:
2245041
39.

In vitro and in vivo growth control of transformed lymphoid cells expressing plasma membrane galactosyltransferase.

Ghanta VK, Hiramoto RN, Parker CA, Kidd VJ, Humphreys-Beher MG.

Oncogene. 1989 Nov;4(11):1337-44.

PMID:
2510114
40.

Naltrexone blocks the expression of the conditioned elevation of natural killer cell activity in BALB/c mice.

Solvason HB, Hiramoto RN, Ghanta VK.

Brain Behav Immun. 1989 Sep;3(3):247-62.

PMID:
2482096
41.

Regression of MOPC 104E plasmacytoma with monoclonal anti-idiotype antibodies.

Kodama K, Ghanta VK, Hiramoto NS, Hiramoto RN.

J Biol Response Mod. 1989 Aug;8(4):385-96.

PMID:
2754437
42.
43.

Immunoregulation of murine plasmacytoma. I. Generation of anomalous killer cells in vitro by cocultivation with MOPC 104E.

Hayashida I, Hiramoto RN, Shrestha K, Ghanta VK.

Cancer Invest. 1989;7(1):17-26.

PMID:
2567619
44.
45.

Augmentation of natural immunity and regulation of tumor growth by conditioning.

Ghanta VK, Miura T, Hiramoto NS, Hiramoto RN.

Ann N Y Acad Sci. 1988;521:29-42.

PMID:
3377365
46.
47.

Modulation of immune response. A possible role for murine salivary epidermal and nerve growth factors.

Dean DH, Hiramoto RN, Ghanta VK.

J Periodontol. 1987 Jul;58(7):498-500.

PMID:
3498024
48.

Regulation of natural immunity (NK activity) by conditioning.

Hiramoto RN, Hiramoto NS, Solvason HB, Ghanta VK.

Ann N Y Acad Sci. 1987;496:545-52.

PMID:
3037977
49.

Conditioned enhancement of natural killer cell activity, but not interferon, with camphor or saccharin-LiCl conditioned stimulus.

Ghanta VK, Hiramoto NS, Solvason HB, Tyring SK, Spector NH, Hiramoto RN.

J Neurosci Res. 1987;18(1):10-5.

PMID:
2824798
50.

In vitro effect of monoclonal anti-idiotype antibodies (anti-M104E) on MOPC 104E myeloma cells.

Kodama K, Ghanta VK, Hiramoto RN, Stohrer RC, Kearney JF.

Cancer Res. 1986 Mar;46(3):1250-4.

Supplemental Content

Loading ...
Support Center